| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 20, 2006
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its third quarter fiscal 2006 on Thursday, April 27, 2006 at approximately 8:30 a.m. (ET). The...
-
Apr 11, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that its shareholder Rights Agreement expired on April 10, 2006. The Company said there were no plans to renew it. The Perrigo...
-
Mar 21, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market terconazole vaginal...
-
Mar 10, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) invites the public to access a webcast of Chairman, President and CEO, Dave Gibbons' presentation at the Bank of America 2006 Consumer Conference on...
-
Mar 7, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market Ciclopirox Olamine Cream USP,...
-
Mar 2, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that Chief Financial Officer Douglas R. Schrank will retire from his post on June 30, 2006. Judy L. Brown, Senior Vice President and...
-
Feb 22, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that, through a partnership with InvaGen Pharmaceuticals, it has received tentative approval from the U.S. Food and Drug...
-
Feb 21, 2006Authorizes Extension of Share Repurchase Program
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced the appointment by the Board of Directors of Ran Gottfried as a new director of the Company. Mr. Gottfried was appointed to serve for...
-
Feb 15, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.0425 per share, payable on March 21, 2006 to shareholders of record...
-
Feb 2, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market over-the-counter (OTC) nicotine polarcrilex...
-
Feb 2, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for the second quarter of fiscal year 2006 ended Dec. 24, 2005. The acquisition of Agis Industries was completed on March 17,...
-
Jan 27, 2006
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its second quarter fiscal 2006 on Thursday, Feb. 2, 2006 at approximately 8:30 a.m. (ET). The...
-
Jan 10, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market Desoximetasone Gel USP,...
-
Oct 28, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.0425 per share, payable on December 20, 2005 to shareholders of...
-
Oct 27, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for the first quarter of fiscal year 2006 ended Sept. 24, 2005. The acquisition of Agis Industries was completed on March 17,...
-
Oct 25, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Perrigo Israel Pharmaceuticals Ltd. (formerly Agis Industries (1983) Ltd.) subsidiary is challenging the patent submitted to...
-
Oct 20, 2005
SCOLR Pharma, Inc. (AMEX: DDD) and Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that they entered into an agreement whereby Perrigo will manufacture and market certain sustained...
-
Oct 20, 2005
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its first quarter fiscal 2006 on Thursday, Oct. 27, 2005 at approximately 8:30 a.m. (ET). The...
-
Oct 7, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced that through a partnership with InvaGen Pharmaceuticals, it has received final approval from the U.S. Food and Drug Administration (FDA) to...
-
Sep 21, 2005
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announces the following Webcast: What: Perrigo Analysts' Meeting When: Thursday, September 22, 2005, 9:00 a.m. - Noon (ET) And Friday, September 23,...
-
Sep 12, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Famotidine Tablets USP,...
-
Sep 7, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for the full year and fourth quarter ended June 25, 2005. The acquisition of Agis Industries was completed on March 17, 2005....
-
Aug 29, 2005
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its fourth quarter and fiscal year 2005 on Wednesday, Sept. 7, 2005 at approximately 8:30 a.m....
-
Aug 25, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that, through a partnership with InvaGen Pharmaceuticals, it has received tentative approval from the U.S. Food and Drug...
-
Aug 5, 2005
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.04 per share, payable on September 20, 2005 to shareholders of record...